ACES: Association of Chemical Engineering Graduate Students
April 1, 2019
2013 Distinguished Young Scholars Seminar
The 2013 winner for best DYSS seminar (selected by our students) is Dr. Sarah Perry from Mathew Tirrell’s group at the Molecular Engineering Institute at the University of Chicago. Her presentation was entitled Stereoregularity Inhibits Complex Coacervation of Polypeptides.
Congratulations Dr. Perry!
2013 Schedule of Speakers:
| Date | Speaker and Lecture Title |
|---|---|
| July 8 | John Blazeck Graduate Student, University of Texas – Austin Converting Y. lipolytica into a platform for biofuel and biochemical production |
| July 15 | Nan Yi Postdoctoral Scholar, Yale University Heterogeneous Catalysis for Sustainable Energy: Atomically Dispersed Metal Clusters for Hydrogen Production from Methanol and Formic Acid Reactions |
| July 22 | Steven Caliari Graduate Student, University of Illinois – Urbana Champaign Spatially-graded collagen scaffolds for engineering orthopedic interfaces and regulating MSC fate |
| July 29 | Andrew White Postdoctoral Scholar, University of Chicago Development and application techniques to more closely unify molecular modeling and experiments for applications in biomaterials, protein modeling, and peptide structure-activity relationships |
| August 5 | Wei Gao Graduate Student, University of California – San Diego Synthetic Micro/Nanomachines and Their Applications: Towards ‘Fantastic Voyage’ |
| August 12 | Sarah Perry Postdoctoral Scholar, University of Chicago Stereoregularity Inhibits Complex Coacervation of Polypeptides |
| August 19 | Shukla Diwakar Postdoctoral Scholar, Stanford University Cloud-based simulations on Google Exacycle provide novel mechanistic insights into conformational transitions in GPCRs and Kinases |
| August 26 | Kimberly Stroka Postdoctoral Scholar, Johns Hopkins University Integration of microfabrication, molecular biology, biophysics, and microscopy techniques in order to understand mechanisms of cell migration, adhesion, and mechanotransduction in the context of metastatic cancer and cardiovascular disease. |